06/26/2023
Dechert Represents abrdn Inc. in Acquisition of Tekla’s Healthcare Closed-End Funds With US$3 Billion in AUM
The deal includes four NYSE-listed healthcare and biotech thematic closed-end funds, totaling US$3 billion in assets under management (AUM).